- Do gadolinium based contrast agents bring new risks?2016 | First Faculty of Medicine
- Gadolinium contrast agents - are they really safe?2017 | Second Faculty of Medicine, Third Faculty of Medicine
- Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous application2018 | Second Faculty of Medicine, Third Faculty of Medicine
- The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study)2015 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents2020 | Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
- Does serial administration of gadolinium-based contrast agents affect patient neurological and neuropsychological status? Fourteen-year follow-up of patients receiving more than fifty contrast administrations2020 | First Faculty of Medicine, Central Library of Charles University, Faculty of Arts
- Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy2022 | First Faculty of Medicine, Third Faculty of Medicine
- Using Transcranial Sonography to Display Intracranial Structures in the B-mode2017 | First Faculty of Medicine
- Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy2022 | Third Faculty of Medicine
- Age-related magnetic susceptibility changes in deep grey matter and cerebral cortex of normal young and middle-aged adults depicted by whole brain analysis2021 | First Faculty of Medicine